<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39204279</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-0817</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>10</Day></PubDate></JournalIssue><Title>Pathogens (Basel, Switzerland)</Title><ISOAbbreviation>Pathogens</ISOAbbreviation></Journal><ArticleTitle>Conference Report: LPMHealthcare Emerging Viruses 2023 (EVOX23): Pandemics-Learning from the Past and Present to Prepare for the Future.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">679</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/pathogens13080679</ELocationID><Abstract><AbstractText>The emergence of SARS-CoV-2 has meant that pandemic preparedness has become a major focus of the global scientific community. Gathered in the historic St Edmund Hall college in Oxford, the one-day LPMHealthcare conference on emerging viruses (6 September 2023) sought to review and learn from past pandemics-the current SARS-CoV-2 pandemic and the Mpox outbreak-and then look towards potential future pandemics. This includes an emphasis on monitoring the "traditional" reservoirs of viruses with zoonotic potential, as well as possible new sources of spillover events, e.g., bats, which we are coming into closer contact with due to climate change and the impacts of human activities on habitats. Continued vigilance and investment into creative scientific solutions is required for issues including the long-term physical and psychological effects of COVID-19, i.e., long COVID. The evaluation of current systems, including environmental monitoring, communication (with the public, regulatory authorities, and governments), and training; assessment of the effectiveness of the technologies/assays we have in place currently; and lobbying of the government and the public to work with scientists are all required in order to build trust moving forward. Overall, the SARS-CoV-2 pandemic has shown how many sectors can work together to achieve a global impact in times of crisis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jenkins</LastName><ForeName>Fern</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>UKHSA, Porton Down, Salisbury SP4 0JG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mapulanga</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Medway School of Pharmacy, The Universities of Kent and Greenwich at Medway, Chatham ME4 4BF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thapa</LastName><ForeName>Gauri</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Medway School of Pharmacy, The Universities of Kent and Greenwich at Medway, Chatham ME4 4BF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Costa</LastName><ForeName>Kelly A S</ForeName><Initials>KAS</Initials><Identifier Source="ORCID">0000-0001-6352-3843</Identifier><AffiliationInfo><Affiliation>Medway School of Pharmacy, The Universities of Kent and Greenwich at Medway, Chatham ME4 4BF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Temperton</LastName><ForeName>Nigel J</ForeName><Initials>NJ</Initials><Identifier Source="ORCID">0000-0002-7978-3815</Identifier><AffiliationInfo><Affiliation>Medway School of Pharmacy, The Universities of Kent and Greenwich at Medway, Chatham ME4 4BF, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016423">Congress</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pathogens</MedlineTA><NlmUniqueID>101596317</NlmUniqueID><ISSNLinking>2076-0817</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">methodology development</Keyword><Keyword MajorTopicYN="N">pandemics</Keyword><Keyword MajorTopicYN="N">preparedness</Keyword><Keyword MajorTopicYN="N">zoonotic viruses</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>29</Day><Hour>1</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39204279</ArticleId><ArticleId IdType="pmc">PMC11357271</ArticleId><ArticleId IdType="doi">10.3390/pathogens13080679</ArticleId><ArticleId IdType="pii">pathogens13080679</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hammond J.A.B., Rolland W., Shore T.H.G. Purulent bronchitis: A study of cases occurring amongst the british troops at a base in france. Lancet. 1917;190:41&#x2013;46. doi: 10.1016/S0140-6736(01)56229-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(01)56229-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams A., Hallows N., Eyre J.W.H., French H. Purulent bronchitis: Its influenzal and pneumococcal bacteriology. Lancet. 1917;190:377&#x2013;382. doi: 10.1016/S0140-6736(01)52169-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(01)52169-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson D.R., Simonsen L., Edelson P.J., Morse S.S. Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City. Proc. Natl. Acad. Sci. USA. 2005;102:11059&#x2013;11063. doi: 10.1073/pnas.0408290102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0408290102</ArticleId><ArticleId IdType="pmc">PMC1182402</ArticleId><ArticleId IdType="pubmed">16046546</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomes N. &#x201c;Destroyer and teacher&#x201d;: Managing the masses during the 1918&#x2013;1919 influenza pandemic. Public Health Rep. 2010;125((Suppl. 3)):48&#x2013;62. doi: 10.1177/00333549101250S308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00333549101250S308</ArticleId><ArticleId IdType="pmc">PMC2862334</ArticleId><ArticleId IdType="pubmed">20568568</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrono L.V., Vrancken B., Budt M., D&#xfc;x A., Lequime S., Boral S., Gilbert M.T.P., Gogarten J.F., Hoffmann L., Horst D., et al. Archival influenza virus genomes from Europe reveal genomic variability during the 1918 pandemic. Nat. Commun. 2022;13:2314. doi: 10.1038/s41467-022-29614-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29614-9</ArticleId><ArticleId IdType="pmc">PMC9090925</ArticleId><ArticleId IdType="pubmed">35538057</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina R.A., Manicassamy B., Stertz S., Seibert C.W., Hai R., Belshe R.B., Frey S.E., Basler C.F., Palese P., Garc&#xed;a-Sastre A. Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus. Nat. Commun. 2010;1:28. doi: 10.1038/ncomms1026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms1026</ArticleId><ArticleId IdType="pmc">PMC2964451</ArticleId><ArticleId IdType="pubmed">20975689</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew F., Efstathiou C., Fontanella S., Richardson M., Saunders R., Swieboda D., Sidhu J.K., Ascough S., Moore S.C., Mohamed N., et al. Large scale phenotyping of long COVID inflammation reveals mechanistic subtypes of disease. medRxiv. 2023 doi: 10.1101/2023.06.07.23291077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.06.07.23291077</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Skorniewska Z., Hampshire A., Chalmers J.D., Ho L.-P., Horsley A., Marks M., Poinasamy K., Raman B., Leavy O.C., et al. Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization. Nat. Med. 2023;29:2498&#x2013;2508. doi: 10.1038/s41591-023-02525-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02525-y</ArticleId><ArticleId IdType="pmc">PMC10579097</ArticleId><ArticleId IdType="pubmed">37653345</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann D.M., Whettlock E.M., Liu S., Arachchillage D.J., Boyton R.J. The immunology of long COVID. Nat. Rev. Immunol. 2023;23:618&#x2013;634. doi: 10.1038/s41577-023-00904-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00904-7</ArticleId><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Genova C., Sampson A., Scott S., Cantoni D., Mayora-Neto M., Bentley E., Mattiuzzo G., Wright E., Derveni M., Auld B., et al. Production, Titration, Neutralisation, Storage and Lyophilisation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lentiviral Pseudotypes. Bio Protoc. 2021;11:e4236. doi: 10.21769/BioProtoc.4236.</Citation><ArticleIdList><ArticleId IdType="doi">10.21769/BioProtoc.4236</ArticleId><ArticleId IdType="pmc">PMC8595416</ArticleId><ArticleId IdType="pubmed">34859134</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson C.P., Grayson N.E., Paton R.S., Bolton J.S., Louren&#xe7;o J., Penman B.S., Lee L.N., Odon V., Mongkolsapaya J., Chinnakannan S., et al. Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020. Eurosurveillance. 2020;25:2000685. doi: 10.2807/1560-7917.ES.2020.25.42.2000685.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.42.2000685</ArticleId><ArticleId IdType="pmc">PMC7651873</ArticleId><ArticleId IdType="pubmed">33094713</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantoni D., Mayora-Neto M., Nadesalingam A., Wells D.A., Carnell G.W., Ohlendorf L., Ferrari M., Palmer P., Chan A.C.Y., Smith P., et al. Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody Thresholds. Front. Immunol. 2022;13:773982. doi: 10.3389/fimmu.2022.773982.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.773982</ArticleId><ArticleId IdType="pmc">PMC8940306</ArticleId><ArticleId IdType="pubmed">35330908</ArticleId></ArticleIdList></Reference><Reference><Citation>Atti A., Insalata F., Carr E.J., Otter A.D., Castillo-Olivares J., Wu M., Harvey R., Howell M., Chan A., Lyall J., et al. Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study. J. Infect. 2022;85:545&#x2013;556. doi: 10.1016/j.jinf.2022.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.09.004</ArticleId><ArticleId IdType="pmc">PMC9458758</ArticleId><ArticleId IdType="pubmed">36089104</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantoni D., Wilkie C., Bentley E.M., Mayora-Neto M., Wright E., Scott S., Ray S., Castillo-Olivares J., Heeney J.L., Mattiuzzo G., et al. Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature. Front. Immunol. 2023;14:1184362. doi: 10.3389/fimmu.2023.1184362.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1184362</ArticleId><ArticleId IdType="pmc">PMC10544934</ArticleId><ArticleId IdType="pubmed">37790941</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantoni D., Mayora-Neto M., Thakur N., Elrefaey A.M.E., Newman J., Vishwanath S., Nadesalingam A., Chan A., Smith P., Castillo-Olivares J., et al. Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients. Commun. Biol. 2022;5:409. doi: 10.1038/s42003-022-03325-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-03325-9</ArticleId><ArticleId IdType="pmc">PMC9065041</ArticleId><ArticleId IdType="pubmed">35505237</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuekprakhon A., Nutalai R., Dijokaite-Guraliuc A., Zhou D., Ginn H.M., Selvaraj M., Liu C., Mentzer A.J., Supasa P., Duyvesteyn H.M.E., et al. Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell. 2022;185:2422&#x2013;2433.e13. doi: 10.1016/j.cell.2022.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.005</ArticleId><ArticleId IdType="pmc">PMC9181312</ArticleId><ArticleId IdType="pubmed">35772405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp S.A., Collier D.A., Datir R.P., Ferreira I., Gayed S., Jahun A., Hosmillo M., Rees-Spear C., Mlcochova P., Lumb I.U., et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature. 2021;592:277&#x2013;282. doi: 10.1038/s41586-021-03291-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03291-y</ArticleId><ArticleId IdType="pmc">PMC7610568</ArticleId><ArticleId IdType="pubmed">33545711</ArticleId></ArticleIdList></Reference><Reference><Citation>Dijokaite-Guraliuc A., Das R., Zhou D., Ginn H.M., Liu C., Duyvesteyn H.M.E., Huo J., Nutalai R., Supasa P., Selvaraj M., et al. Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses. Cell Rep. 2023;42:112271. doi: 10.1016/j.celrep.2023.112271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.112271</ArticleId><ArticleId IdType="pmc">PMC9988707</ArticleId><ArticleId IdType="pubmed">36995936</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells D.A., Cantoni D., Mayora-Neto M., Genova C.D., Sampson A., Ferrari M., Carnell G., Nadesalingam A., Smith P., Chan A., et al. Human seasonal coronavirus neutralization and COVID-19 severity. J. Med. Virol. 2022;94:4820&#x2013;4829. doi: 10.1002/jmv.27937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27937</ArticleId><ArticleId IdType="pmc">PMC9349487</ArticleId><ArticleId IdType="pubmed">35705514</ArticleId></ArticleIdList></Reference><Reference><Citation>Knezevic I., Mattiuzzo G., Page M., Minor P., Griffiths E., Nuebling M., Moorthy V. WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: Call for urgent action by the scientific community. Lancet Microbe. 2022;3:e235&#x2013;e240. doi: 10.1016/S2666-5247(21)00266-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(21)00266-4</ArticleId><ArticleId IdType="pmc">PMC8547804</ArticleId><ArticleId IdType="pubmed">34723229</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorne L.G., Reuschl A.-K., Zuliani-Alvarez L., Whelan M.V.X., Turner J., Noursadeghi M., Jolly C., Towers G.J. SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation. EMBO J. 2021;40:e107826. doi: 10.15252/embj.2021107826.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021107826</ArticleId><ArticleId IdType="pmc">PMC8209947</ArticleId><ArticleId IdType="pubmed">34101213</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorne L.G., Bouhaddou M., Reuschl A.-K., Zuliani-Alvarez L., Polacco B., Pelin A., Batra J., Whelan M.V.X., Hosmillo M., Fossati A., et al. Evolution of enhanced innate immune evasion by SARS-CoV-2. Nature. 2022;602:487&#x2013;495. doi: 10.1038/s41586-021-04352-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04352-y</ArticleId><ArticleId IdType="pmc">PMC8850198</ArticleId><ArticleId IdType="pubmed">34942634</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster T.L., Wilson H., Iyer S.S., Coss K., Doores K., Smith S., Kellam P., Finzi A., Borrow P., Hahn B.H., et al. Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction. Cell Host Microbe. 2016;20:429&#x2013;442. doi: 10.1016/j.chom.2016.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.08.006</ArticleId><ArticleId IdType="pmc">PMC5075283</ArticleId><ArticleId IdType="pubmed">27640936</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhaddou M., Reuschl A.-K., Polacco B.J., Thorne L.G., Ummadi M.R., Ye C., Rosales R., Pelin A., Batra J., Jang G.M., et al. Global landscape of the host response to SARS-CoV-2 variants reveals viral evolutionary trajectories. bioRxiv. 2022 doi: 10.1101/2022.10.19.512927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.10.19.512927</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhaddou M., Reuschl A.-K., Polacco B.J., Thorne L.G., Ummadi M.R., Ye C., Rosales R., Pelin A., Batra J., Jang G.M., et al. SARS-CoV-2 variants evolve convergent strategies to remodel the host response. Cell. 2023;186:4597&#x2013;4614.e26. doi: 10.1016/j.cell.2023.08.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.08.026</ArticleId><ArticleId IdType="pmc">PMC10604369</ArticleId><ArticleId IdType="pubmed">37738970</ArticleId></ArticleIdList></Reference><Reference><Citation>Otter A.D., Jones S., Hicks B., Bailey D., Callaby H., Houlihan C., Rampling T., Gordon N.C., Selman H., Satheshkumar P.S., et al. Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals. Nat. Commun. 2023;14:5948. doi: 10.1038/s41467-023-41587-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-41587-x</ArticleId><ArticleId IdType="pmc">PMC10517934</ArticleId><ArticleId IdType="pubmed">37741831</ArticleId></ArticleIdList></Reference><Reference><Citation>Herfst S., Begeman L., Spronken M.I., Poen M.J., Eggink D., de Meulder D., Lexmond P., Bestebroer T.M., Koopmans M.P.G., Kuiken T., et al. A Dutch highly pathogenic H5N6 avian influenza virus showed remarkable tropism for extra-respiratory organs and caused severe disease but was not transmissible via air in the ferret model. mSphere. 2023;8:e0020023. doi: 10.1128/msphere.00200-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/msphere.00200-23</ArticleId><ArticleId IdType="pmc">PMC10449504</ArticleId><ArticleId IdType="pubmed">37428085</ArticleId></ArticleIdList></Reference><Reference><Citation>Taubenberger J.K., Reid A.H., Lourens R.M., Wang R., Jin G., Fanning T.G. Characterization of the 1918 influenza virus polymerase genes. Nature. 2005;437:889&#x2013;893. doi: 10.1038/nature04230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04230</ArticleId><ArticleId IdType="pubmed">16208372</ArticleId></ArticleIdList></Reference><Reference><Citation>Ag&#xfc;ero M., Monne I., S&#xe1;nchez A., Zecchin B., Fusaro A., Ruano M.J., Del Valle Arrojo M., Fern&#xe1;ndez-Antonio R., Souto A.M., Tordable P., et al. Highly pathogenic avian influenza A(H5N1) virus infection in farmed minks, Spain, October 2022. Eurosurveillance. 2023;28:2300001. doi: 10.2807/1560-7917.ES.2023.28.3.2300001.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2023.28.3.2300001</ArticleId><ArticleId IdType="pmc">PMC9853945</ArticleId><ArticleId IdType="pubmed">36695488</ArticleId></ArticleIdList></Reference><Reference><Citation>Seekings A.H., Warren C.J., Thomas S.S., Mahmood S., James J., Byrne A.M.P., Watson S., Bianco C., Nunez A., Brown I.H., et al. Highly pathogenic avian influenza virus H5N6 (clade 2.3.4.4b) has a preferable host tropism for waterfowl reflected in its inefficient transmission to terrestrial poultry. Virology. 2021;559:74&#x2013;85. doi: 10.1016/j.virol.2021.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2021.03.010</ArticleId><ArticleId IdType="pubmed">33839461</ArticleId></ArticleIdList></Reference><Reference><Citation>Sila T., Sunghan J., Laochareonsuk W., Surasombatpattana S., Kongkamol C., Ingviya T., Siripaitoon P., Kositpantawong N., Kanchanasuwan S., Hortiwakul T., et al. Suspected Cat-to-Human Transmission of SARS-CoV-2, Thailand, July-September 2021. Emerg. Infect. Dis. 2022;28:1485&#x2013;1488. doi: 10.3201/eid2807.212605.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2807.212605</ArticleId><ArticleId IdType="pmc">PMC9239874</ArticleId><ArticleId IdType="pubmed">35666777</ArticleId></ArticleIdList></Reference><Reference><Citation>Oude Munnink B.B., Sikkema R.S., Nieuwenhuijse D.F., Molenaar R.J., Munger E., Molenkamp R., van der Spek A., Tolsma P., Rietveld A., Brouwer M., et al. Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans. Science. 2021;371:172&#x2013;177. doi: 10.1126/science.abe5901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe5901</ArticleId><ArticleId IdType="pmc">PMC7857398</ArticleId><ArticleId IdType="pubmed">33172935</ArticleId></ArticleIdList></Reference><Reference><Citation>Willgert K., Didelot X., Surendran-Nair M., Kuchipudi S.V., Ruden R.M., Yon M., Nissly R.H., Vandegrift K.J., Nelli R.K., Li L., et al. Transmission history of SARS-CoV-2 in humans and white-tailed deer. Sci. Rep. 2022;12:12094. doi: 10.1038/s41598-022-16071-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-16071-z</ArticleId><ArticleId IdType="pmc">PMC9284484</ArticleId><ArticleId IdType="pubmed">35840592</ArticleId></ArticleIdList></Reference><Reference><Citation>Apaa T., Withers A.J., Staley C., Blanchard A., Bennett M., Bremner-Harrison S., Chadwick E.A., Hailer F., Harrison S.W.R., Loose M., et al. Sarbecoviruses of British horseshoe bats; sequence variation and epidemiology. J. Gen. Virol. 2023;104:001859. doi: 10.1099/jgv.0.001859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.001859</ArticleId><ArticleId IdType="pubmed">37319000</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher A.M., Airey G., Liu Y., Gemmell M., Thomas J., Bentley E.G., Whitehead M.A., Paxton W.A., Pollakis G., Paterson S., et al. The ecology of viruses in urban rodents with a focus on SARS-CoV-2. Emerg. Microbes Infect. 2023;12:2217940. doi: 10.1080/22221751.2023.2217940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2217940</ArticleId><ArticleId IdType="pmc">PMC10262798</ArticleId><ArticleId IdType="pubmed">37219409</ArticleId></ArticleIdList></Reference><Reference><Citation>Holding M., Otter A.D., Dowall S., Takumi K., Hicks B., Coleman T., Hemingway G., Royds M., Findlay-Wilson S., Curran-French M., et al. Screening of wild deer populations for exposure to SARS-CoV-2 in the United Kingdom, 2020-2021. Transbound. Emerg. Dis. 2022;69:e3244&#x2013;e3249. doi: 10.1111/tbed.14534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tbed.14534</ArticleId><ArticleId IdType="pmc">PMC9115462</ArticleId><ArticleId IdType="pubmed">35338581</ArticleId></ArticleIdList></Reference><Reference><Citation>Ip H.S., Griffin K.M., Messer J.D., Winzeler M.E., Shriner S.A., Killian M.L., K. Torchetti M., DeLiberto T.J., Amman B.R., Cossaboom C.M., et al. An Opportunistic Survey Reveals an Unexpected Coronavirus Diversity Hotspot in North America. Viruses. 2021;13:2016. doi: 10.3390/v13102016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13102016</ArticleId><ArticleId IdType="pmc">PMC8539472</ArticleId><ArticleId IdType="pubmed">34696445</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan C., Wu Y., Rui X., Yang Y., Ling C., Liu S., Liu S., Wang Y. Animal models for COVID-19: Advances, gaps and perspectives. Signal Transduct. Target. Ther. 2022;7:220. doi: 10.1038/s41392-022-01087-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01087-8</ArticleId><ArticleId IdType="pmc">PMC9261903</ArticleId><ArticleId IdType="pubmed">35798699</ArticleId></ArticleIdList></Reference><Reference><Citation>Negredo A., Palacios G., V&#xe1;zquez-Mor&#xf3;n S., Gonz&#xe1;lez F., Dopazo H., Molero F., Juste J., Quetglas J., Savji N., de la Cruz Mart&#xed;nez M., et al. Discovery of an ebolavirus-like filovirus in europe. PLoS Pathog. 2011;7:e1002304. doi: 10.1371/journal.ppat.1002304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002304</ArticleId><ArticleId IdType="pmc">PMC3197594</ArticleId><ArticleId IdType="pubmed">22039362</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemenesi G., T&#xf3;th G.E., Mayora-Neto M., Scott S., Temperton N., Wright E., M&#xfc;hlberger E., Hume A.J., Suder E.L., Zana B., et al. Isolation of infectious Lloviu virus from Schreiber&#x2019;s bats in Hungary. Nat. Commun. 2022;13:1706. doi: 10.1038/s41467-022-29298-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29298-1</ArticleId><ArticleId IdType="pmc">PMC8971391</ArticleId><ArticleId IdType="pubmed">35361761</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xf3;th G.E., Hume A.J., Suder E.L., Zeghbib S., &#xc1;brah&#xe1;m &#xc1;., Lanszki Z., Varga Z., Tauber Z., F&#xf6;ldes F., Zana B., et al. Isolation and genome characterization of Lloviu virus from Italian Schreibers&#x2019;s bats. Sci. Rep. 2023;13:11310. doi: 10.1038/s41598-023-38364-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-38364-7</ArticleId><ArticleId IdType="pmc">PMC10344946</ArticleId><ArticleId IdType="pubmed">37443182</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;rf&#xf6;l T., T&#xf3;th G.E., Boldogh S.A., Jakab F., Kemenesi G. Lloviu Virus in Europe is an Emerging Disease of Concern. Ecohealth. 2022;19:5&#x2013;7. doi: 10.1007/s10393-021-01574-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10393-021-01574-4</ArticleId><ArticleId IdType="pmc">PMC9090692</ArticleId><ArticleId IdType="pubmed">35107640</ArticleId></ArticleIdList></Reference><Reference><Citation>Storm N., Jansen Van Vuren P., Markotter W., Paweska J.T. Antibody Responses to Marburg Virus in Egyptian Rousette Bats and Their Role in Protection against Infection. Viruses. 2018;10:73. doi: 10.3390/v10020073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10020073</ArticleId><ArticleId IdType="pmc">PMC5850380</ArticleId><ArticleId IdType="pubmed">29439384</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno K.R., Weinberg M., Harten L., Salinas Ramos V.B., Herrera M.L., Czirj&#xe1;k G., Yovel Y. Sick bats stay home alone: Fruit bats practice social distancing when faced with an immunological challenge. Ann. N. Y. Acad. Sci. 2021;1505:178&#x2013;190. doi: 10.1111/nyas.14600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.14600</ArticleId><ArticleId IdType="pmc">PMC9290741</ArticleId><ArticleId IdType="pubmed">33876431</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Rosario J.M.M., da Costa K.A.S., Temperton N.J. Pseudotyped Viruses for Influenza. Adv. Exp. Med. Biol. 2023;1407:153&#x2013;173. doi: 10.1007/978-981-99-0113-5_8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-99-0113-5_8</ArticleId><ArticleId IdType="pubmed">36920696</ArticleId></ArticleIdList></Reference><Reference><Citation>da Costa K.A.S., Del Rosario J.M.M., Ferrari M., Vishwanath S., Asbach B., Kinsley R., Wagner R., Heeney J.L., Carnell G.W., Temperton N.J. Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design. Vaccines. 2022;10:1520. doi: 10.3390/vaccines10091520.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10091520</ArticleId><ArticleId IdType="pmc">PMC9571397</ArticleId><ArticleId IdType="pubmed">36146598</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara F., Del Rosario J.M.M., da Costa K.A.S., Kinsley R., Scott S., Fereidouni S., Thompson C., Kellam P., Gilbert S., Carnell G., et al. Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies. Front. Immunol. 2021;12:661379. doi: 10.3389/fimmu.2021.661379.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.661379</ArticleId><ArticleId IdType="pmc">PMC8182064</ArticleId><ArticleId IdType="pubmed">34108964</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnell G.W., Trombetta C.M., Ferrara F., Montomoli E., Temperton N.J. Correlation of Influenza B Haemagglutination Inhibiton, Single-Radial Haemolysis and Pseudotype-Based Microneutralisation Assays for Immunogenicity Testing of Seasonal Vaccines. Vaccines. 2021;9:100. doi: 10.3390/vaccines9020100.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9020100</ArticleId><ArticleId IdType="pmc">PMC7911544</ArticleId><ArticleId IdType="pubmed">33525543</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaiotto T., Ramage W., Ball C., Risley P., Carnell G.W., Temperton N., Engelhardt O.G., Hufton S.E. Nanobodies mapped to cross-reactive and divergent epitopes on A(H7N9) influenza hemagglutinin using yeast display. Sci. Rep. 2021;11:3126. doi: 10.1038/s41598-021-82356-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-82356-4</ArticleId><ArticleId IdType="pmc">PMC7862619</ArticleId><ArticleId IdType="pubmed">33542302</ArticleId></ArticleIdList></Reference><Reference><Citation>Shipley R., Wright E., Smith S.P., Selden D., Fooks A.R., Banyard A.C. Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus. Viruses. 2022;14:2750. doi: 10.3390/v14122750.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122750</ArticleId><ArticleId IdType="pmc">PMC9781811</ArticleId><ArticleId IdType="pubmed">36560754</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyasulu P.S., Weyer J., Tschopp R., Mihret A., Aseffa A., Nuvor S.V., Tamuzi J.L., Nyakarahuka L., Helegbe G.K., Ntinginya N.E., et al. Rabies mortality and morbidity associated with animal bites in Africa: A case for integrated rabies disease surveillance, prevention and control: A scoping review. BMJ Open. 2021;11:e048551. doi: 10.1136/bmjopen-2020-048551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048551</ArticleId><ArticleId IdType="pmc">PMC8640643</ArticleId><ArticleId IdType="pubmed">34857556</ArticleId></ArticleIdList></Reference><Reference><Citation>Shipley R., Wright E., Lean F.Z.X., Selden D., Horton D.L., Fooks A.R., Banyard A.C. Assessing Rabies Vaccine Protection against a Novel Lyssavirus, Kotalahti Bat Lyssavirus. Viruses. 2021;13:947. doi: 10.3390/v13050947.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13050947</ArticleId><ArticleId IdType="pmc">PMC8161192</ArticleId><ArticleId IdType="pubmed">34065574</ArticleId></ArticleIdList></Reference><Reference><Citation>Shipley R., Wright E., Selden D., Wu G., Aegerter J., Fooks A.R., Banyard A.C. Bats and Viruses: Emergence of Novel Lyssaviruses and Association of Bats with Viral Zoonoses in the EU. Trop. Med. Infect. Dis. 2019;4:31. doi: 10.3390/tropicalmed4010031.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed4010031</ArticleId><ArticleId IdType="pmc">PMC6473451</ArticleId><ArticleId IdType="pubmed">30736432</ArticleId></ArticleIdList></Reference><Reference><Citation>Kydyrmanov A., Sayatov M., Karamendin K., Zhumatov K., Asanova S., Daulbayeva K., Starick E., Fereidouni S. Monitoring of influenza A viruses in wild bird populations in Kazakhstan in 2002-2009. Arch. Virol. 2017;162:147&#x2013;155. doi: 10.1007/s00705-016-3076-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-016-3076-4</ArticleId><ArticleId IdType="pubmed">27695951</ArticleId></ArticleIdList></Reference><Reference><Citation>Fereidouni S., Starick E., Karamendin K., Genova C.D., Scott S.D., Khan Y., Harder T., Kydyrmanov A. Genetic characterization of a new candidate hemagglutinin subtype of influenza A viruses. Emerg. Microbes Infect. 2023;12:2225645. doi: 10.1080/22221751.2023.2225645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2225645</ArticleId><ArticleId IdType="pmc">PMC10308872</ArticleId><ArticleId IdType="pubmed">37335000</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina J.P., Brady O.J., Scott T.W., Zou C., Pigott D.M., Duda K.A., Bhatt S., Katzelnick L., Howes R.E., Battle K.E., et al. Global spread of dengue virus types: Mapping the 70 year history. Trends Microbiol. 2014;22:138&#x2013;146. doi: 10.1016/j.tim.2013.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2013.12.011</ArticleId><ArticleId IdType="pmc">PMC3946041</ArticleId><ArticleId IdType="pubmed">24468533</ArticleId></ArticleIdList></Reference><Reference><Citation>Everitt A.R., Clare S., Pertel T., John S.P., Wash R.S., Smith S.E., Chin C.R., Feeley E.M., Sims J.S., Adams D.J., et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature. 2012;484:519&#x2013;523. doi: 10.1038/nature10921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10921</ArticleId><ArticleId IdType="pmc">PMC3648786</ArticleId><ArticleId IdType="pubmed">22446628</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickenhagen A., Sugrue E., Lytras S., Kuchi S., Noerenberg M., Turnbull M.L., Loney C., Herder V., Allan J., Jarmson I., et al. A prenylated dsRNA sensor protects against severe COVID-19. Science. 2021;374:eabj3624. doi: 10.1126/science.abj3624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj3624</ArticleId><ArticleId IdType="pmc">PMC7612834</ArticleId><ArticleId IdType="pubmed">34581622</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan S.L., Ganji G., Paeper B., Proll S., Katze M.G. Systems biology and the host response to viral infection. Nat. Biotechnol. 2007;25:1383&#x2013;1389. doi: 10.1038/nbt1207-1383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt1207-1383</ArticleId><ArticleId IdType="pmc">PMC7097743</ArticleId><ArticleId IdType="pubmed">18066032</ArticleId></ArticleIdList></Reference><Reference><Citation>Wani S.A., Sahu A.R., Saxena S., Hussain S., Pandey A., Kanchan S., Sahoo A.P., Mishra B., Tiwari A.K., Mishra B.P., et al. Systems biology approach: Panacea for unravelling host-virus interactions and dynamics of vaccine induced immune response. Gene Rep. 2016;5:23&#x2013;29. doi: 10.1016/j.genrep.2016.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genrep.2016.08.002</ArticleId><ArticleId IdType="pmc">PMC7104209</ArticleId><ArticleId IdType="pubmed">32289096</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Sancho L., Tripathi S., Rodriguez-Frandsen A., Pache L., Sanchez-Aparicio M., McGregor M.J., Haas K.M., Swaney D.L., Nguyen T.T., Mamede J.I., et al. Restriction factor compendium for influenza A virus reveals a mechanism for evasion of autophagy. Nat. Microbiol. 2021;6:1319&#x2013;1333. doi: 10.1038/s41564-021-00964-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-00964-2</ArticleId><ArticleId IdType="pmc">PMC9683089</ArticleId><ArticleId IdType="pubmed">34556855</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Sancho L., Lewinski M.K., Pache L., Stoneham C.A., Yin X., Pratt D., Churas C., Rosenthal S.B., Liu S., De Jesus P.D., et al. Functional Landscape of SARS-CoV-2 Cellular Restriction. bioRxiv. 2020 doi: 10.2139/ssrn.3698891.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3698891</ArticleId><ArticleId IdType="pmc">PMC8043580</ArticleId><ArticleId IdType="pubmed">33930332</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>